Zhenyu Ji
- Oncology top 10%
- Cancer-related Molecular Pathways 5
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 3
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 14
- Protein Degradation and Inhibitors 4
- Physiology top 10%
-
- Bioactive Compounds and Antitumor Agents 3
-
- Microbial Natural Products and Biosynthesis 3
-
- Computational Drug Discovery Methods 3
- Co-authors
- Fang MeiXiaodong ChengTamara TsalkovaHensin TsaoJingwu XieKeith T. FlahertyMichael TaylorRaj Kumar
- Journals
- Journal of Biological Chemistry (2 papers)Angewandte Chemie International Edition (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Zhenyu Ji
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Oncology 394
- Molecular Biology 901
- Cancer Research 138
- Physiology 30
- Cell Biology 92
Countries citing papers authored by Zhenyu Ji
This map shows the geographic impact of Zhenyu Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Ji more than expected).
Fields of papers citing papers by Zhenyu Ji
This network shows the impact of papers produced by Zhenyu Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Ji. The network helps show where Zhenyu Ji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhenyu Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 9 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 42 | |
| 12 | 2016 | 7 | |
| 13 | 2014 | 96 | |
| 14 | 2013 | 29 | |
| 15 | 2013 | 12 | |
| 16 | 2011 | 59 | |
| 17 | 2010 | 18 | |
| 18 | 2009 | 11 | |
| 19 | 2008 | 296 | |
| 20 | 2007 | 50 |
About Zhenyu Ji
Zhenyu Ji is a scholar working on Toxicology, Oncology and Immunology and Allergy, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (14 papers), Cancer-related Molecular Pathways (5 papers), CAR-T cell therapy research (4 papers), Protein Degradation and Inhibitors (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Microbial Natural Products and Biosynthesis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Oncology (394 citations), Molecular Biology (901 citations) and Cancer Research (138 citations). Zhenyu Ji has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Fang Mei, Xiaodong Cheng, Tamara Tsalkova, Xiaodong Cheng, Hensin Tsao, Jingwu Xie, Keith T. Flaherty, Michael Taylor, Raj Kumar and Benchun Miao. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.